SCOTLAND'S first medical cannabis production facility has secured £2 million in private investment to become one of the largest producers in the UK.
Hilltop Leaf founders Hamish Clegg, Neil Ewart, and Will Ewart have secured the money from UK investment house Traditum and a number of private investors. The equity injection will allow the company to make its first commercial sales and scale up its infrastructure for the specialist prescription market.
Hilltop Leaf – which holds a manufacturers "specials" licence and wholesaler dealer authorisation from the Medicines and Healthcare Products Regulatory Agency – has already completed construction of an 11,000sqm production facility in southern Scotland.
The company intends to produce pharmaceutical-grade cannabis-based products for medicinal use in humans (CBPMs) which will ultimately be processed on site.
When fully operational, the founders say the facility will have the potential to supply more than 10 per cent of the UK market, creating dozens of local jobs.
"We are building a business around the three key pillars of health innovation, environmental sustainability, and community impact," said Clegg, the company's chief executive.
"Although medicinal cannabis use is growing, the UK relies solely on imports and we understand there is a problem with the reliability of the supply chain.
“We aim to provide an affordable, high-quality solution to treat conditions ranging from chronic pain to severe epilepsy, while easing pressure on the NHS. We plan to rival other countries such as Canada, Germany and Israel with our own reliable supply from the hills of Scotland.”
The company was set up in 2019 by Clegg, a former financier and serial entrepreneur, with father and son Neil and Will Ewart who have a track record in windfarms and agriculture. The company has a research partnership with Nottingham Trent University which specialises in testing and clinical trials.
An estimated 1.8 million people in the UK use "black market" cannabis to treat medical conditions, according to the Centre for Medicinal Cannabis. Medicinal cannabis was legalised in 2018 and is now used by more than 20,000 patients in the UK, with uptake expected to grow rapidly.
Tom Hurley, investment director with Traditum, said: “Hilltop Leaf is Traditum’s third healthtech deal in six months and will add further strength to our growing portfolio. We believe cannabis has the potential to offer new and better treatments for some conditions and provide an alternative to opioids for pain relief.
“We have been impressed by the strength of the company’s management team, their fastidious approach to quality and their vision to create a purpose-built facility backed by research and development. Hilltop Leaf has the chance to gain an early mover advantage and become a clear leader in the UK’s emerging medicinal cannabis industry.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel